Drugs / AIDSVAX B/E
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00006327 | Mar 1999 → Aug 2000 | HIV infectious disease | VaxGen | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AIDSVAX B/E | “The purpose of this study is to determine if the vaccine, AIDSVAX B/E, will protect intravenous drug users from becoming infected with HIV.” NCT00006327 ↗ |
| Modality | Vaccine | “The AIDSVAX B/E HIV vaccine trial was a randomized, double-blind, placebo-controlled trial.” PMID 20079620 ↗ Jan 2010 |